It appears that they are setting up a future trial as a combo. I think it was highlighted on StockTwits. Need to have nih trial to complete and release data. Investors getting tired of the wait even though it’s really the difficulty of the trial and nih that’s the problem, not the company specifically. Maybe elevate does read out first.